All In Biotech

Drug Trial Radar · NCT06459063

Intra-articular Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint

A Placebo-controlled Study of Intra-articular Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint

Last checked: Nov 19, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

46

Planned (sponsor's estimate)

Start

Jun 10, 2024

Primary completion

Sep 2026

Study completion Jan 2027

Sponsor

Lead sponsor
Kaplan Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 14, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a single center trial to assess the safety and efficacy of intra-articular administration of Allocetra to patients with 1st CMC thumb joint osteoarthritis (OA).

Conditions

  • Osteoarthritis Thumb

Interventions

  • Allocetra - Safety run-in phaseDrug

    Intra-articular injection of Allocetra performed once on Day 1 of the study at different doses.

  • PlaceboOther

    Intra-articular injection of placebo solution containing all excipients except for the Allocetra cells.

  • Allocetra - Randomization phaseDrug

    Intra-articular injection of selected dose of Allocetra based on the safety run-in, performed on Day 1 of the study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Injection-related reactionsTime frame: Day 0 (Treatment visit).
  2. Treatment emergent adverse eventsTime frame: Day 0 to 6 months.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kaplan Medical Center

    Rehovot, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.